The Spectrum IQ system also builds upon proven Spectrum infusion pump technology and Baxter’s comprehensive approach to patient safety to help make drug library compliance, protection for high-risk ...
DEERFIELD, Ill., & SALT LAKE CITY--(BUSINESS WIRE)-- Intermountain Healthcare and Baxter Healthcare Corporation today announced the successful integration of the SIGMA Spectrum Infusion System into ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International (NYSE: BAX) this week announced the results of a retrospective analysis of data from Sigma Spectrum Infusion System pumps that found 90 percent ...
Baxter International Inc BAX has issued an urgent correction for its Spectrum V8 and Spectrum IQ infusion pumps, applicable in the U.S. and Puerto Rico, due to a ...
Baxter International issued an urgent device correction Oct. 29 related to all of its Spectrum infusion pumps. The devicemaker said that deviations from specific cleaning methods may impair the pumps’ ...
Though new software and other technologies can hugely improve safety and efficiency in healthcare by automating and preprogramming some of the most precise processes in a hospital, there are also ...
On April 20, 2022, Rapid7 discovered vulnerabilities in two TCP/IP–enabled medical devices produced by Baxter Healthcare. The flaws, four in total, affected the company’s SIGMA Spectrum Infusion Pump ...
Shares of Baxter International Inc. ( BAX) upped nearly 1% following the disclosure of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation SIGMA Spectrum Infusion ...
As predicted, not long after Baxter International issued an urgent safety communication about an issue with some of its Spectrum infusion pumps, it has been upgraded to a full-blown recall complete ...
DEERFIELD, Ill., December 11, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The ...
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the U.S. Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results